A fascinating shift is taking place in Afghanistan's healthcare landscape, and it's all about the power of Indian medicines. An Afghan vlogger's experience has sparked a conversation about the rising popularity of Indian pharmaceuticals in the country.
In a recent post, an Afghan vlogger, Fazal Afghan, shared his eye-opening encounter with Indian medicines. He revealed how a simple trip to buy paracetamol led him to discover the incredible value and effectiveness of Indian-made pharmaceuticals. Fazal was initially seeking a trusted brand, Parol, common in Pakistan and Turkey, but the pharmacist offered a game-changing alternative: Indian-made paracetamol tablets, four times cheaper and reportedly more effective.
Intrigued, Fazal gave the Indian tablets a try, and they didn't disappoint. Not only did they relieve his headache swiftly, but they also sparked a realization: Indian medicines are quietly taking over the Afghan market, replacing their Pakistani counterparts.
But here's where it gets controversial...
This shift in preference is a result of a series of clashes between Afghanistan and Pakistan, which has led to a significant drop in Pakistan's market share in the Afghan pharmaceutical industry. In fact, Afghanistan's Deputy Prime Minister, Abdul Ghani Baradar, recently declared a ban on Pakistani medicines, citing poor quality, and urged traders to explore alternatives from India, Iran, and Central Asia.
And this is the part most people miss...
Afghanistan's reliance on Pakistani pharmaceuticals has deep roots, dating back decades. With its landlocked geography and fragile domestic healthcare industry, Afghanistan has historically depended on Pakistan for essential medical supplies. However, the recent border clashes and the resulting closure of key border crossings have severely disrupted this dependence, leading to critical medicine shortages in the country.
Enter India, a savior in Afghanistan's time of need. In November 2025, as Afghanistan grappled with the consequences of a medicine shortage, India's External Affairs Minister, S Jaishankar, announced an emergency airlift of 73 tonnes of life-saving medical supplies to Kabul. This wasn't India's first act of medical generosity towards Afghanistan. India has consistently provided medical aid, from vaccines to advanced medical equipment, and even set up long-term healthcare facilities like the Indira Gandhi Children's Hospital, which has been operating since 1969.
But India's support goes beyond emergency shipments. India has committed to building and upgrading major healthcare facilities in Kabul, including an Oncology Centre, Trauma Centre, and Thalassaemia Centre. Additionally, Indian pharmaceutical companies are making significant inroads into the Afghan market. Indian pharma major Zydus Lifesciences signed a landmark $100 million MoU with Afghanistan's Rofi's International Group, which will not only focus on exports but also technology transfer and local manufacturing to reduce import dependency.
So, Fazal Afghan's choice to opt for Indian painkillers over familiar brands is a microcosm of a macro-level transformation in Afghanistan's healthcare supply chain.
What do you think about this shift? Is it a positive development for Afghanistan's healthcare industry? Or are there potential challenges and considerations that we should be mindful of? We'd love to hear your thoughts in the comments below!
